ArticleEmerging infectious diseases2012
Outbreak-associated novel duck Reovirus, China, 2011.
Article in Emerging infectious diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- Genomic characterization and pathogenicity assessment of a novel strain of duck reovirus identified in China.Frontiers in microbiology · 2026Article
- Development of duplex crystal digital PCR (dPCR) assay for detection and differentiation of NDRV and MDRV.Veterinary and animal science · 2025Article
- Update on Reovirus Infections in Waterfowls.Animals : an open access journal from MDPI · 2025Review
- Reoviral Hepatitis in Young Turkey Poults-An Emerging Problem.Pathogens (Basel, Switzerland) · 2025Article
- Establishment of a Visual Gene Chip Method for the Simultaneous Detection of Seven Waterfowl Virus Pathogens.Viruses · 2025Article
- Genetics and biological characteristics of duck reoviruses isolated from ducks and geese in China.Veterinary research · 2025Article
- Novel Duck Orthoreovirus σA Protein Inhibits Interferon Signaling by Impeding STAT1/STAT2 Nuclear Translocation.Transboundary and emerging diseases · 2025Article
- Isolation, Genomic Characterization, and Pathogenicity of a Novel Duck Orbivirus Genetically Similar to Corriparta Virus in China.Transboundary and emerging diseases · 2025Article
- Review
- Characterization and pathogenicity evaluation of recombinant novel duck reovirus isolated from Southeast China.Frontiers in veterinary science · 2023Article
- Identification and molecular characterization of novel duck reoviruses in Henan Province, China.Frontiers in veterinary science · 2023Article
- Article
- Development and Evaluation of a Monoclonal Antibody-Based Blocking Enzyme-Linked Immunosorbent Assay for the Detection of Antibodies against Novel Duck Reovirus in Waterfowl Species.Microbiology spectrum · 2022Article
- Detection and Identification of Avian Reovirus in Young Geese (Animals : an open access journal from MDPI · 2022Article
- Article
- Novel duck reovirus exhibits pathogenicity to specific pathogen-free chickens by the subcutaneous route.Scientific reports · 2021Article
- A TaqMan-based real-time PCR assay for specific detection of novel duck reovirus in China.BMC veterinary research · 2020Article
- Interaction between Translocation-associated membrane protein 1 and σC protein of novel duck reovirus controls virus infectivity.Virus genes · 2020Article
- Quantitative Proteomic Analysis of Duck Embryo Fibroblasts Infected With Novel Duck Reovirus.Frontiers in veterinary science · 2020Article
- Characterization of Monoclonal Antibodies against σA Protein and Cross-Reactive Epitope Identification and Application for Detection of Duck and Chicken Reovirus Infections.Pathogens (Basel, Switzerland) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.